Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease
Standard
Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease. / Sebastianutto, Irene; Cenci, Maria Angela; Fieblinger, Tim.
In: NEUROBIOL DIS, Vol. 105, 09.2017, p. 117-131.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease
AU - Sebastianutto, Irene
AU - Cenci, Maria Angela
AU - Fieblinger, Tim
N1 - Copyright © 2017 Elsevier Inc. All rights reserved.
PY - 2017/9
Y1 - 2017/9
N2 - Striatal neurons forming the indirect pathway (iSPNs) are particularly vulnerable in Huntington's disease (HD). In this study we set out to investigate morphological and physiological alterations of iSPNs in two mouse models of HD with relatively slow disease progression (long CAG repeat R6/2 and zQ175-KI). Both were crossed with a transgenic mouse line expressing eGFP in iSPNs. Using the open-field and rotarod tests, we first defined two time points in relation to the occurrence of motor deficits in each model. Then, we investigated electrophysiological and morphological properties of iSPNs at both ages. Both HD models exhibited increased iSPN excitability already before the onset of motor deficits, associated with a reduced number of primary dendrites and decreased function of Kir- and voltage-gated potassium channels. Alterations that specifically occurred at symptomatic ages included increased calcium release by back-propagating action potentials in proximal dendrites, due to enhanced engagement of intracellular calcium stores. Moreover, motorically impaired mice of both HD models showed a reduction in iSPN spine density and progressive formation of huntingtin (Htt) aggregates in the striatum. Our study therefore reports iSPN-specific alterations relative to the development of a motor phenotype in two different mouse models of HD. While some alterations occur early and are partly non-progressive, others potentially provide a pathophysiological marker of an overt disease state.
AB - Striatal neurons forming the indirect pathway (iSPNs) are particularly vulnerable in Huntington's disease (HD). In this study we set out to investigate morphological and physiological alterations of iSPNs in two mouse models of HD with relatively slow disease progression (long CAG repeat R6/2 and zQ175-KI). Both were crossed with a transgenic mouse line expressing eGFP in iSPNs. Using the open-field and rotarod tests, we first defined two time points in relation to the occurrence of motor deficits in each model. Then, we investigated electrophysiological and morphological properties of iSPNs at both ages. Both HD models exhibited increased iSPN excitability already before the onset of motor deficits, associated with a reduced number of primary dendrites and decreased function of Kir- and voltage-gated potassium channels. Alterations that specifically occurred at symptomatic ages included increased calcium release by back-propagating action potentials in proximal dendrites, due to enhanced engagement of intracellular calcium stores. Moreover, motorically impaired mice of both HD models showed a reduction in iSPN spine density and progressive formation of huntingtin (Htt) aggregates in the striatum. Our study therefore reports iSPN-specific alterations relative to the development of a motor phenotype in two different mouse models of HD. While some alterations occur early and are partly non-progressive, others potentially provide a pathophysiological marker of an overt disease state.
KW - Action Potentials/drug effects
KW - Animals
KW - Cadmium Chloride/pharmacology
KW - Cesium/pharmacology
KW - Chlorides/pharmacology
KW - Corpus Striatum/pathology
KW - Dendrites/metabolism
KW - Disease Models, Animal
KW - Exploratory Behavior/physiology
KW - Huntingtin Protein/genetics
KW - Huntington Disease/complications
KW - Mice
KW - Mice, Inbred C57BL
KW - Mice, Transgenic
KW - Movement Disorders/etiology
KW - Neurons/drug effects
KW - Potassium/pharmacology
KW - Psychomotor Performance/physiology
KW - Sodium Channel Blockers/pharmacology
KW - Tetrodotoxin/pharmacology
KW - Trinucleotide Repeat Expansion/genetics
U2 - 10.1016/j.nbd.2017.05.011
DO - 10.1016/j.nbd.2017.05.011
M3 - SCORING: Journal article
C2 - 28578004
VL - 105
SP - 117
EP - 131
JO - NEUROBIOL DIS
JF - NEUROBIOL DIS
SN - 0969-9961
ER -